Get started
Author

Sehhoon Park

High liver fibrosis index FIB‐4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers
2014 · Beomseok Suh, Sehhoon Park, et al. · Hepatology · 121
DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC
2019 · Sehhoon Park, Hayoon Lee, et al. · Journal of Thoracic Oncology · 86
PDF
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
2023 · Hyunsu Kim, Sehhoon Park, et al. · Journal for ImmunoTherapy of Cancer · 60
PDF
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma
2019 · Sehhoon Park, Je-Gun Joung, et al. · Journal for ImmunoTherapy of Cancer · 51
PDF
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
2022 · Sehhoon Park, Jae Myoung Noh, et al. · European Journal of Cancer · 46
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 Trial
2022 · Jiyun Lee, Jiae Koh, et al. · Journal of Thoracic Oncology · 37
PDF
Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma
2017 · Yeonghun Lee, Sehhoon Park, et al. · BMC Cancer · 33
PDF
Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy
2016 · Sehhoon Park, Hwi Young Kim, et al. · Medicine · 28
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance
2023 · Soohyun Hwang, Tae Hee Hong, et al. · Modern Pathology · 25
PDF
Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial
2023 · Mangyeong Lee, Danbee Kang, et al. · Supportive Care in Cancer · 24
PDF
Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB ‐4 liver fibrosis index
2015 · Beomseok Suh, Jae Moon Yun, et al. · Cancer · 24
Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells
2023 · Se‐Hoon Lee, Yeongmin Kim, et al. · Advanced Science · 23
PDF
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)
2022 · Hyun Ae Jung, Miso Kim, et al. · Journal of Thoracic Oncology · 23
PDF
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer
2022 · Kyung Hwan Kim, Hongryull Pyo, et al. · International Journal of Radiation Oncology*Biology*Physics · 23
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2023 · Hana Kim, Sehhoon Park, et al. · Cancer Research and Treatment · 22
PDF
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy
2022 · Kyung Hwan Kim, Hongryull Pyo, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment
2021 · Soohyun Hwang, Tae Hee Hong, et al. · Translational Lung Cancer Research · 18
PDF
Prognostic value of p21‐activated kinase 4 in resected pancreatic cancer
2017 · Sehhoon Park, Jin Won Kim, et al. · Apmis · 18
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
2021 · Hye Ryeon Kim, Su Jin Lee, et al. · Cancer Research and Treatment · 16
PDF
The clinical efficacy of olaparib monotherapy or combination with ceralasertib (AZD6738) in relapsed small cell lung cancer.
2021 · Sehhoon Park, Peter G. Mortimer, et al. · Journal of Clinical Oncology · 15
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer
2020 · Sehhoon Park, Eunjin Lee, et al. · Molecular Cancer Research · 15
Metabolic parameters on baseline 18F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
2022 · Hye Ryeong Kwon, Junhun Cho, et al. · Frontiers in Medicine · 14
PDF
Biomarker driven phase II umbrella trial study of AZD1775, AZD2014, AZD2811 monotherapy in relapsed small cell lung cancer.
2019 · Sehhoon Park, Joonho Shim, et al. · Journal of Clinical Oncology · 13
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
2022 · Jihoon Ko, Jaeyun Jung, et al. · Pathology & Oncology Research · 11
Lung Cancer in Korea
2021 · Sehhoon Park, Chang-Min Choi, et al. · Journal of Thoracic Oncology · 11
PDF
Works count: 133
Citation count: 917
H-index: 18
I10-index: 25
Year
Topic
Type